Announcements Trials

Browse Landscape

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pre-Eclampsia 1 Lymphoma, Follicular 1

Interventions

Fluticasone-Salmeterol Drug Combination 2 Fluticasone 2 Diclofenac 2 ziconotide 1 secukinumab 1 ropinirole 1 aliskiren 1 acetaminophen, codeine drug combination 1 Venlafaxine Hydrochloride 1 Thiotepa 1 Tacrolimus 1 Sublocade 1 Ribavirin 1 Radiotherapy 1 Quinine 1 Oxycodone 1 Naloxone 1 Ketamine 1 Furosemide 1 Filgrastim 1 Fentanyl 1 Escitalopram 1 Donepezil 1 Cyclophosphamide 1 Buprenorphine, Naloxone Drug Combination 1 Bimatoprost 1 Artesunate 1 Antilymphocyte Serum 1 Amoxicillin-Potassium Clavulanate Combination 1 Amlodipine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Lymphoma, Follicular × Furosemide × Clear all

NCT07167862 2026-01-23

PPPOCUS

University of California, Irvine

Phase 4 Not yet recruiting

Lymphoma, Follicular, Pre-Eclampsia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡